Last reviewed · How we verify
somatostatin, intravenous bolus
somatostatin, intravenous bolus is a Small molecule drug developed by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. It is currently in Phase 3 development.
At a glance
| Generic name | somatostatin, intravenous bolus |
|---|---|
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET (NA)
- Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors (PHASE1, PHASE2)
- 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs) (NA)
- Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
- Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)
- Vasoactive Drugs in Real World Practice (PHASE4)
- Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects (NA)
- The Prophylactic Effect of Stilamin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- somatostatin, intravenous bolus CI brief — competitive landscape report
- somatostatin, intravenous bolus updates RSS · CI watch RSS
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau portfolio CI
Frequently asked questions about somatostatin, intravenous bolus
What is somatostatin, intravenous bolus?
somatostatin, intravenous bolus is a Small molecule drug developed by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.
Who makes somatostatin, intravenous bolus?
somatostatin, intravenous bolus is developed by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (see full Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau pipeline at /company/fundaci-institut-de-recerca-de-l-hospital-de-la-santa-creu-i-sant-pau).
What development phase is somatostatin, intravenous bolus in?
somatostatin, intravenous bolus is in Phase 3.